Our results suggest that AAV-Ren/Ang-transduced mice could be a useful platform for testing specific antihypertensive therapies and demonstrate that AAV-transfer methodology has the potential to make valuable contributions to the specific understanding of the relationship between BP and atherosclerosis. This evidence concerns the gene REN and atherosclerosis.